JIANGSU, China--(BUSINESS WIRE)--Atom Bioscience (Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.), a clinical stage biotechnology company developing new treatments for metabolic and inflammatory ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Patients with uncontrolled gout had additional burdens ...

BLOOM (TAMPA) – Nephrologist Jason B. Rothschild, MD, recently joined Gayle Guyardo, the host of the globally syndicated health and wellness show Bloom, to discuss the often-overlooked connection ...

Sorry, but your browser does not support the video tag. (BPT) – At 21 years old, Khashayar (Khash) B. lived a life similar to any other young adult. He spent time ...

Gout Prevalent in German CKD Cohort In an observational UK study, chronic kidney disease stage 3 or higher was 78% more likely to develop in patients with vs without gout during a median follow-up of ...

Veterans with gout were 30% more likely to be prescribed chronic opioid therapy than those without gout, with factors such as female sex, underweight BMI, current smoking status, and a higher burden ...

Dear Dr. Roach: Since January, I have had gout in my right big toe five times. I was given methylprednisolone (four-mg dose packs) five times. The medicine works only to the point of getting rid of ...

Gout, a form of arthritis caused by uric acid buildup, often manifests as sudden, intense foot pain, particularly in the big ...

JIANGSU, China--(BUSINESS WIRE)--Atom Bioscience (Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.), a clinical stage biotechnology company developing new treatments for inflammatory and metabolic ...

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech ...

(MENAFN- EIN Presswire) EINPresswire/ -- Overview of the Market: The Global Gout Therapeutics Market has witnessed substantial growth in recent years due to the increasing prevalence of gout and the ...

WATERTOWN, Mass., June 12, 2019 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a clinical-stage biotechnology company focused on unlocking the full potential of biologic therapies based ...